Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MORGAN STANLEY

(MS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Morgan Stanley : Good timing to anticipate a continuation of the trend

07/22/2021 | 02:44am EDT
long trade
Live
Entry price : 95.42$ | Target : 115$ | Stop-loss : 84$ | Potential : 20.52%
Shares in Morgan Stanley show a positive technical chart pattern over the medium term, which suggests that the rising trend should be followed.
Investors have an opportunity to buy the stock and target the $ 115.
Morgan Stanley : Morgan Stanley : Good timing to anticipate a continuation of the trend
Strengths
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses
  • With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
  • The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
  • With an enterprise value anticipated at 5.06 times the sales for the current fiscal year, the company turns out to be overvalued.
Ratings chart
Subsector Other Investment Banking & Brokerage Services
1st jan.Capitalization (M$)Investor Rating
MORGAN STANLEY48.65%186 143
THE CHARLES SCHWAB CORPORAT..56.60%156 817
THE GOLDMAN SACHS GROUP, IN..58.36%147 133
CITIC SECURITIES COMPANY LI..-16.09%47 906
CSC FINANCIAL CO., LTD.-18.35%31 377
CHINA INTERNATIONAL CAPITAL..-9.05%28 122
CHINA MERCHANTS SECURITIES ..-26.65%22 395
RAYMOND JAMES FINANCIAL, IN..59.92%21 062
HUATAI SECURITIES CO., LTD.-12.77%20 942
SHENWAN HONGYUAN GROUP CO.,..-1.33%19 680
GUOSEN SECURITIES CO., LTD.-17.38%17 484
More Results

ę MarketScreener.com 2021

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (USD)
Sales 2021 59 610 M - -
Net income 2021 14 227 M - -
Net Debt 2021 112 B - -
P/E ratio 2021 13,0x
Yield 2021 2,06%
Capitalization 183 B 183 B -
EV / Sales 2021 4,96x
EV / Sales 2022 5,02x
Nbr of Employees 72 000
Free-Float 71,1%
Upcoming event on MORGAN STANLEY
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Last Close Price 101,87 $
Average target price 110,74 $
Spread / Average Target 8,71%
EPS Revisions
Managers and Directors
James Patrick Gorman Chairman & Chief Executive Officer
Andrew Michael Saperstein Co-President
Edward N. Pick Co-President
Sharon Yeshaya Chief Financial Officer
Robert P. Rooney Head-Technology, Operations & Firm Resilience